109 related articles for article (PubMed ID: 21761311)
1. Subcellular renal proximal tubular mitochondrial toxicity with tenofovir treatment.
Kohler JJ; Hosseini SH
Methods Mol Biol; 2011; 755():267-77. PubMed ID: 21761311
[TBL] [Abstract][Full Text] [Related]
2. Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters.
Kohler JJ; Hosseini SH; Green E; Abuin A; Ludaway T; Russ R; Santoianni R; Lewis W
Lab Invest; 2011 Jun; 91(6):852-8. PubMed ID: 21403643
[TBL] [Abstract][Full Text] [Related]
3. Tenofovir renal toxicity targets mitochondria of renal proximal tubules.
Kohler JJ; Hosseini SH; Hoying-Brandt A; Green E; Johnson DM; Russ R; Tran D; Raper CM; Santoianni R; Lewis W
Lab Invest; 2009 May; 89(5):513-9. PubMed ID: 19274046
[TBL] [Abstract][Full Text] [Related]
4. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.
Côté HC; Magil AB; Harris M; Scarth BJ; Gadawski I; Wang N; Yu E; Yip B; Zalunardo N; Werb R; Hogg R; Harrigan PR; Montaner JS
Antivir Ther; 2006; 11(1):79-86. PubMed ID: 16518963
[TBL] [Abstract][Full Text] [Related]
5. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
Irizarry-Alvarado JM; Dwyer JP; Brumble LM; Alvarez S; Mendez JC
AIDS Read; 2009 Mar; 19(3):114-21. PubMed ID: 19334328
[TBL] [Abstract][Full Text] [Related]
6. Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir.
Gérard L; Chazallon C; Taburet AM; Girard PM; Aboulker JP; Piketty C
Antivir Ther; 2007; 12(1):31-9. PubMed ID: 17503745
[TBL] [Abstract][Full Text] [Related]
7. An introduction to nucleoside and nucleotide analogues.
Squires KE
Antivir Ther; 2001; 6 Suppl 3():1-14. PubMed ID: 11678469
[TBL] [Abstract][Full Text] [Related]
8. [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
de la Prada FJ; Prados AM; Tugores A; Uriol M; Saus C; Morey A
Nefrologia; 2006; 26(5):626-30. PubMed ID: 17117909
[TBL] [Abstract][Full Text] [Related]
9. Renal safety of tenofovir disoproxil fumarate.
Sax PE; Gallant JE; Klotman PE
AIDS Read; 2007 Feb; 17(2):90-2, 99-104, C3. PubMed ID: 17323508
[TBL] [Abstract][Full Text] [Related]
10. Effect of tenofovir on renal glomerular and tubular function.
Fux CA; Christen A; Zgraggen S; Mohaupt MG; Furrer H
AIDS; 2007 Jul; 21(11):1483-5. PubMed ID: 17589197
[TBL] [Abstract][Full Text] [Related]
11. Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy.
Winston A; Amin J; Mallon P; Marriott D; Carr A; Cooper DA; Emery S
HIV Med; 2006 Mar; 7(2):105-11. PubMed ID: 16420255
[TBL] [Abstract][Full Text] [Related]
12. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
Psevdos G; Gonzalez E; Sharp V
AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
[TBL] [Abstract][Full Text] [Related]
13. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
Gallant JE; Parish MA; Keruly JC; Moore RD
Clin Infect Dis; 2005 Apr; 40(8):1194-8. PubMed ID: 15791522
[TBL] [Abstract][Full Text] [Related]
14. Update on mitochondrial toxicity: where are we now?
Walker UA
J HIV Ther; 2003 May; 8(2):32-5. PubMed ID: 12838162
[TBL] [Abstract][Full Text] [Related]
15. Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient.
Perrot S; Aslangul E; Szwebel T; Caillat-Vigneron N; Le Jeunne C
J Clin Rheumatol; 2009 Mar; 15(2):72-4. PubMed ID: 19265350
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.
Muñoz de Benito RM; Arribas López JR
Expert Rev Anti Infect Ther; 2006 Aug; 4(4):523-35. PubMed ID: 17009933
[TBL] [Abstract][Full Text] [Related]
17. K65R, TAMs and tenofovir.
Miller MD
AIDS Rev; 2004; 6(1):22-33. PubMed ID: 15168738
[TBL] [Abstract][Full Text] [Related]
18. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence.
Hall AM; Hendry BM; Nitsch D; Connolly JO
Am J Kidney Dis; 2011 May; 57(5):773-80. PubMed ID: 21435764
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature.
Malik A; Abraham P; Malik N
J Infect; 2005 Aug; 51(2):E61-5. PubMed ID: 16038754
[TBL] [Abstract][Full Text] [Related]
20. Causes and consequences of hypokalemia in patients on tenofovir disoproxil fumarate.
Shepp DH; Curtis S; Rooney JF
AIDS; 2007 Jul; 21(11):1479-81. PubMed ID: 17589195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
